A Double-blind, Randomized Clinical Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 (JSC BIOCAD, Russia) and Soliris in Healthy Volunteers
Latest Information Update: 19 May 2020
At a glance
- Drugs Eculizumab (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Pharmacokinetics
- Sponsors Biocad
Most Recent Events
- 29 Jul 2019 New trial record